Founded on the principles of accessibility and quality care, Bleuler has expanded its services to address mental health and substance use challenges. Bleuler Chemical Dependency (BCD) opened its doors on April 1st, 2011. Through our Chemical Dependency Recovery Services, we provide comprehensive treatment options for alcohol and substance use disorder as well as DWI/DUI assessment services. BCD is fully licensed by the New York State Office of Mental Health (OMH) and the Office of Addiction Services and Supports (OASAS) and has also been designated as an Opioid Prevention site by the Department of Health (DOH). Our programs are designed to be flexible, catering to the unique needs of each client to ensure the best possible outcomes. We offer comprehensive assessment, groups, and treatment planning. Our clinical staff in the substance use program educates and counsel each individual about risk factors and consequences of substance use and risky behaviors. Our approach is to establish a collaborative partnership with our clients, helping them to reinforce their own motivation to change. We utilize Motivational Interviewing, CBT, and Trauma Informed Care. In addition, BCD is also certified as an Opioid Overdose Prevention Program issued by New York Department of Health.

Through comprehensive assessment and treatment planning, our clinical staff in the substance use program will educate and counsel each individual about risk factors and consequences of substance use. Our approach is to establish a collaborative partnership with our patients helping them to reinforce their own motivation to change. We utilize Motivational Interviewing, CBT, and Trauma Informed Care.

We recognize that recovery is a journey and a process supported through sustaining relationships and building social networks. Bleuler Chemical Dependency Recovery Services offers Continuing Care for individuals who have successfully completed the program but would like ongoing clinical support to sustain their recovery.  The purpose of continuing care is to provide ongoing support and “check-in” to manage life and emotional stressors, urges and cravings to avoid or prevent relapse.

Our Psychiatrist in the substance use program is licensed and Board Certified in Addiction Medicine. He understands the complexities of our patients with substance use disorders and coordinates care with treating clinicians.

We offer Medication-Assisted Treatment and Psychopharmacology as part of our treatment regimen to support the recovery process.

BPC Psychiatric Prescribing Position

BPC follows industry best practices when prescribing medications with an increased likelihood of use or dependence.  If prescribed at all, these medications are primarily prescribed on a short-term basis to manage acute symptoms of a severe or disabling nature. Safe, effective, and responsible practice is our primary goal.  This is best achieved with evidence-based psychological interventions in conjunction with pharmacological treatments suitable for long-term use.

Medication-Assisted Treatment (MAT) is the use of FDA- approved medications to treat substance use disorders and prevent opioid overdose. MAT in combination with counseling provides a holistic approach to the treatment of substance use disorders.

The groups in our Substance Use program are offered through a schedule that understands the needs of our patients to balance treatment and day to day obligations through an emphasis on development of more appropriate coping skills as well as relapse prevention.